33 participants
Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2026-02-18
- Completion:
- 2029-12-09
Conditions
- Neoplasms
Interventions
- DRUG
No Results Yet